Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone

American Journal of Physiology. Endocrinology and Metabolism
M Wang, Roger H Unger

Abstract

In obese rodents, excess myocardial lipid accumulation (lipotoxicity) of myocardium may cause cardiomyopathy that in the obese Zucker diabetic fatty (ZDF) fa/fa rat can be prevented by treatment with troglitazone (TGZ). To determine the underlying mechanisms, we measured total 5'-AMP-activated kinase (AMPK) protein and its activated, phosphorylated form, P-AMPK. P-AMPK was significantly reduced in both ZDF fa/fa rat and ob/ob mouse hearts compared with lean, wild-type controls. TGZ treatment of obese ZDF rats, which lowered cardiac lipid content, increased P-AMPK. Expression of protein phosphatase 2C (PP2C), which inactivates AMPK activity by dephosphorylation, was increased in untreated ZDF fa/fa rat hearts, but fell with TGZ treatment, suggesting that PP2C can influence AMPK activity. In cultured myocardiocytes, fatty acids reduced P-AMPK, suggesting a feed-forward effect of lipid overload. Our findings highlight a role of PP2C and AMPK in the derangements of cardiac lipid metabolism in obesity and provide new insights as to the mechanisms of the liporegulatory disorder leading to lipotoxic cardiomyopathy.

References

Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y LeeR H Unger
Oct 6, 1998·Annual Review of Biochemistry·D G HardieM Carlson
Jul 17, 1999·The American Journal of Physiology·W W Winder, D G Hardie
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y T ZhouR H Unger
Mar 25, 2000·Journal of Molecular and Cellular Cardiology·D L Hickson-BickJ B McMillin
Feb 7, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R H Unger, L Orci
Apr 4, 2001·The Journal of Clinical Investigation·H C ChiuJ E Schaffer
Sep 15, 2001·American Journal of Physiology. Heart and Circulatory Physiology·S L LongnusM F Allard
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Jan 18, 2002·Nature·Yasuhiko MinokoshiBarbara B Kahn
Feb 8, 2002·Metabolism: Clinical and Experimental·Susan B RacetteSamuel Klein
Jul 11, 2002·Neurochemistry International·Susanne KlumppJosef Krieglstein
Oct 12, 2002·American Journal of Physiology. Endocrinology and Metabolism·Grith S Olsen, Bo F Hansen
Dec 5, 2002·American Journal of Physiology. Endocrinology and Metabolism·Laura L AtkinsonGary D Lopaschuk
Dec 19, 2002·American Journal of Physiology. Endocrinology and Metabolism·Bella KalderonJacob Bar-Tana
Jan 4, 2003·The Journal of Clinical Investigation·Benoit ViolletSophie Vaulont
Feb 21, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Lidia S SzczepaniakRonald G Victor
Aug 5, 2003·Metabolism: Clinical and Experimental·Martin MuurlingPeter J Voshol
Sep 23, 2003·Endocrinology·Neil B RudermanEdward W Kraegen

❮ Previous
Next ❯

Citations

May 23, 2012·The Journal of Biological Chemistry·Boubacar BenzianeAlexander V Chibalin
Jan 30, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jingying WangJi Li
Jan 8, 2008·Clinical and Experimental Pharmacology & Physiology·Ming-Hui Zou, Yong Wu
Feb 28, 2009·Acta Physiologica·N L Dzamko, G R Steinberg
Feb 26, 2009·Acta Physiologica·A S KimL H Young
Oct 21, 2010·American Journal of Physiology. Endocrinology and Metabolism·Gene HsiaoDorothy D Sears
Aug 20, 2009·American Journal of Physiology. Endocrinology and Metabolism·Qun LiJun Ren
Mar 13, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Suthat LiangpunsakulDavid W Crabb
Aug 21, 2009·American Journal of Physiology. Renal Physiology·I Alexandru BobulescuOrson W Moe
Sep 8, 2007·The Journal of Clinical Investigation·Ni-Huiping SonIra J Goldberg
Jul 26, 2007·Lipids in Health and Disease·ZengKui Guo
Jan 21, 2012·The Review of Diabetic Studies : RDS·Maria A Guzzardi, Patricia Iozzo
Dec 21, 2004·Biochemical and Biophysical Research Communications·Gabriela SuchankovaThomas W Gettys
Feb 15, 2011·Journal of Obesity·Joselyn RojasValmore Bermúdez
Aug 11, 2016·Inflammopharmacology·Amin HasanvandShahram Ejtemaei Mehr
Sep 4, 2007·Medical Hypotheses·Zengkui Guo
Dec 26, 2006·Journal of Molecular and Cellular Cardiology·Girish KewalramaniBrian Rodrigues
Aug 27, 2005·World Journal of Gastroenterology : WJG·Ting-Kai LeungHung-Jung Wang
Jun 7, 2018·Experimental Physiology·Carol T BusseyRegis R Lamberts
Aug 19, 2007·Circulation Research·Gary D LopaschukWilliam C Stanley
Sep 1, 2012·Circulation Research·Vlad G Zaha, Lawrence H Young
Sep 5, 2007·Circulation·Frederick L Ruberg
Dec 7, 2006·American Journal of Physiology. Endocrinology and Metabolism·Wen GuoJames L Kirkland
Jul 9, 2009·Physiological Reviews·Gregory R Steinberg, Bruce E Kemp
Jun 5, 2010·Critical Reviews in Biochemistry and Molecular Biology·Benoit ViolletFabrizio Andreelli
Mar 23, 2012·Journal of Bioenergetics and Biomembranes·Belma TuranGuy Vassort
Oct 10, 2014·Biology of Reproduction·Thi Mong Diep NguyenElisabeth Blesbois
Jul 12, 2020·The Journal of Biological Chemistry·Peng Zhao, Alan R Saltiel
Aug 2, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhiyong ZhangBeatrice Haimovich
Apr 7, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaoling HeDeqiang Huang
Apr 23, 2017·Journal of Cachexia, Sarcopenia and Muscle·Kerstin BoenglerSusanne Rohrbach
Aug 27, 2005·World Journal of Gastroenterology : WJG·Fabio MarraMaurizio Parola
Aug 25, 2005·American Journal of Physiology. Endocrinology and Metabolism·Sarah J LessardJohn A Hawley
Aug 23, 2020·Biomedicines·Antonio J López-GamberoFernando Rodríguez de Fonseca
Nov 7, 2016·Cellular and Molecular Life Sciences : CMLS·Tian LiYang Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.